Type of Facility: SR&ED Financing
Days to Fund: 19
Use of Funds: Millions of dollars have been invested in this company’s breakthrough treatment. To pay for significant expenses associated with certification, Venbridge provided a bridge facility to assist the company to extend its runway to commercialization.
Company Background: This company is developing platform technology to increase the absorption of drugs in difficult-to-penetrate tissues.